Aimed Alliance Endorses the Cancer Patients’ Timely Treatment Bill of Rights

Aimed Alliance joins a growing chorus of patient advocacy organizations calling on health insurers to provide fair, timely, and transparent access to cancer treatment

By Alliance for Proton Therapy Access | October 4, 2018

Aimed Alliance Endorses the Cancer Patients’ Timely Treatment Bill of Rights

Aimed Alliance joins a growing chorus of patient advocacy organizations calling on health insurers to provide fair, timely, and transparent access to cancer treatment

 

WASHINGTON, D.C. — The Alliance for the Adoption of Innovations in Medicine (Aimed Alliance) today announced its endorsement of the Cancer Patients’ Timely Treatment Bill of Rights. Created to address opaque and unfair insurance review processes, the Bill of Rights establishes principles that hold insurers accountable for providing fair, timely, and transparent access to doctor-recommended cancer treatment. Aimed Alliance joined other patient advocacy organizations and patient advocates in calling for an end to the undue physical, emotional, and financial stress that result from improper insurance delays and denials.

 

“Cancer patients wait days, weeks, or even months for an appeal process to play out while their cancer and anxiety grow,” said Daniel E. Smith, Executive Director of the Alliance for Proton Therapy Access. “Patients and their doctors should be focused on fighting cancer, not insurance companies. This endorsement from the Aimed Alliance adds an important voice to a growing list of organizations demanding accountability.”

 

“We are proud to endorse the Cancer Patients’ Timely Treatment Bill of Right,” said Stacey Worthy, counsel to Aimed Alliance. “We believe that bill of rights outlines common-sense principles that are critical to improving access to evidence-based treatments and technologies for all cancer patients.”

 

Other patient advocacy organizations that have endorsed the Cancer Patients’ Timely Treatment Bill of Right include Critical Mass and The Doctor-Patient Rights Project.

 

###

 

About the Alliance for Proton Therapy Access

The Alliance for Proton Therapy Access is an advocacy organization comprising a growing community of patients, families, caregivers, physicians, and industry partners working together to make sure all cancer patients seeking proton therapy receive fair and timely payment decisions from their health insurers. The Alliance is governed by a Board of Directors made up of patients, physicians and industry partners. Sign up to be an advocate and learn more about the Alliance at allianceforprotontherapy.org. Follow the Alliance on Facebook and Twitter.

 

About Aimed Alliance

Established in 2013 and based in Washington, DC, Aimed Alliance is a not-for-profit organization that seeks to improve access to quality health care. Aimed Alliance achieves this mission by conducting legal research and analysis; developing economically sound, patient-centered recommendations; and disseminating our findings to inform policymakers and increase public awareness.